On Jan. 25 2023, Seqalis broadcasted a live expert panel on immuno-oncology and quantitative TCR sequencing. The webinar was organized by Seqalis with the collaboration of the Institut de Duve (UCLouvain, Be) and PDC-Line Pharma (Be/Fr). The expert panel was composed of Dr Sophie Lucas, President of de Duve Institute (UCLouvain, Be), Eric Halioua, CEO of PDC-Line Pharma (Fr/Be), Dr Joël Plumas, CSO of PDC-Line Pharma (Be/Fr) and Dr Javier Carrasco, clinical oncologist at the Grand Hôpital de Charleroi (Be) and Medical Advisor of Seqalis. The webinar turned out to be an overwhelming success...